DNA Marker Predicts MDS Treatment Response
DNA Marker Predicts MDS Treatment Response
DNA Marker Predicts MDS Treatment Response
Key points
اہم نکات
मुख्य बातें
- Researchers at the Sylvester Comprehensive Cancer Center have found a DNA marker that can predict how patients with myelodysplastic syndromes, a group of blood cancers, will respond to treatment.
- The finding could help doctors choose the right therapy sooner and spare patients treatments that are unlikely to work.
- The team says the marker is a step toward more personalised care for people living with MDS.
- Researchers at the Sylvester Comprehensive Cancer Center have found a DNA marker that can predict how patients with myelodysplastic syndromes, a group of blood cancers, will respond to treatment.
- The finding could help doctors choose the right therapy sooner and spare patients treatments that are unlikely to work.
- The team says the marker is a step toward more personalised care for people living with MDS.
- Researchers at the Sylvester Comprehensive Cancer Center have found a DNA marker that can predict how patients with myelodysplastic syndromes, a group of blood cancers, will respond to treatment.
- The finding could help doctors choose the right therapy sooner and spare patients treatments that are unlikely to work.
- The team says the marker is a step toward more personalised care for people living with MDS.
Researchers at the Sylvester Comprehensive Cancer Center have found a DNA marker that can predict how patients with myelodysplastic syndromes, a group of blood cancers, will respond to treatment. The finding could help doctors choose the right therapy sooner and spare patients treatments that are unlikely to work. The team says the marker is a step toward more personalised care for people living with MDS.
Researchers at the Sylvester Comprehensive Cancer Center have found a DNA marker that can predict how patients with myelodysplastic syndromes, a group of blood cancers, will respond to treatment. The finding could help doctors choose the right therapy sooner and spare patients treatments that are unlikely to work. The team says the marker is a step toward more personalised care for people living with MDS.
Researchers at the Sylvester Comprehensive Cancer Center have found a DNA marker that can predict how patients with myelodysplastic syndromes, a group of blood cancers, will respond to treatment. The finding could help doctors choose the right therapy sooner and spare patients treatments that are unlikely to work. The team says the marker is a step toward more personalised care for people living with MDS.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।